Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst S.r.l. Irccs
Clinical trials sponsored by Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst S.r.l. Irccs, explained in plain language.
-
5-Day radiation blitz tested for deadly lung cancer
Disease control OngoingThis study is testing a shorter, 5-day course of targeted radiation for people with malignant pleural mesothelioma, a serious cancer often linked to asbestos. The treatment is given after surgery or a diagnostic biopsy. The main goal is to see if this faster schedule is safe and …
Phase: NA • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Radiation 'Trojan Horse' tested against multiple advanced cancers
Disease control OngoingThis trial is testing whether a targeted radiation therapy that works for prostate cancer might also help people with other advanced cancers. The treatment uses a radioactive drug that seeks out and attaches to a specific marker (PSMA) found on some cancer cells or their blood ve…
Phase: PHASE2 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC